Citigroup »

Rapt Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $974k 39k 24.86
2023-09-30 $692k 42k 16.62
2023-03-31 $2.0M 111k 18.35
2022-12-31 $1.7M 86k 19.80
2022-09-30 $1.6M 66k 24.06
2021-12-31 $2.5M 69k 36.73
2021-03-31 $30k 1.4k 22.01
2020-12-31 $69k 3.5k 19.67
2020-09-30 $19k 527 35.29
2020-06-30 $35k 1.5k 23.53
2020-03-31 $9.8k 417 23.53
2019-12-31 $7.4k 313 23.53